What is PT-141 used for?

PT-141, also known as bremelanotide, is FDA approved as Vyleesi for hypoactive sexual desire disorder in premenopausal women. It is sold more broadly as a research chemical marketed for sexual dysfunction in general, including in men, but its specific FDA approval covers only that one indication and population.

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of sexual health and hormone peptides. PT-141, melanotan, oxytocin, gonadorelin, and kisspeptin-10.